Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines

Peptides

Volumn 17, Issue 4, 1996, Pages 665-673

  Tallett, A ^a   Chilvers, E R ^a   Mackinnon, A C ^a   Haslett, C ^a   Sethi, T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Focal adhesion kinase; Growth; Neuropeptide; Signal transduction; Small cell lung cancer; Tyrosine kinase activity; Tyrosine phosphorylation

Indexed keywords

BOMBESIN; BOMBESIN ANTAGONIST; BRADYKININ; BRADYKININ ANTAGONIST; GASTRIN; NEUROPEPTIDE; NEUROTENSIN; PROTEIN TYROSINE KINASE; SUBSTANCE P ANTAGONIST;

ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0029994016     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00055-1     Document Type: Article

References (28)

1. 1. Battey, J. F.; Way, J. M.; Corjay, M. H.; et al. Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc. Natl. Acad Sci. USA 88:395-399; 1991.
2. 2. Bepler, G.; Rotsch, M.; Jaques, G.; et al. Peptides and growth factors in small-cell lung cancer: Production, binding sites, and growth effects. J Cancer Res. Clin. Oncol. 114:235-44; 1988.
3. 3. Bunn, P. J.; Dienhart, D. G.; Chan, D.; et al. Neuropeptide stimulation of calcium flux in human lung cancer cells: Delineation of alternative pathways. Proc. Natl. Acad. Sci. USA 87:2162-2166; 1990.
4. 4. Carney, D. N.; Gazdar, A. F.; Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung. Cancer Res. 40:1820-1823; 1980.
5. 5. Coy, D. H.; Taylor, J. E.; Jiang, N. Y.; et al. Short-chain pseudo-peptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity, J. Biol. Chem. 264:14691-14697; 1989.
6. 6. Cuttitta, F.; Carney, D. N.; Mulshine, J.; et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823-826; 1985.
7. 7. Gazdar, A. F.; Carney, D. N. Endocrine properties of small-cell carcinoma of the lung. In: Becker, K. L.; Gazdar, A. F., eds. The endocrine lung in health and disease. London: W. B. Saunders Co.; 1984:501-508.
8. 8. Langdon, S.; Sethi, T.; Ritchie, A.; Muir, M.; Smyth, J.; Rozengurt, E. Broad spectrum neuropeptide antagonists inhibit the growth of small-cell lung cancer in vivo. Cancer Res. 52:4554-4557; 1992.
9. 2+-induced regulation of ion channel and MAP kinase functions. Nature 376:737-745; 1995.
10. 10. Panaretto, B. A. Aspects of growth factor signal transduction in the cytoplasm. J. Cell Sci. 107:747-752; 1994.
11. 11. Rankin, S.; Mori, N.; Narumiya, S.; Rozengurt, E. Botulinum C3 exoenzyme blocks tyrosine phosphorylation of p125FAK and paxillin induced by bombesin and endothelin. FEBS Lett. 354:315-319; 1994.
12. 11] substance P causes apoptosis in lung cancer cell lines. Biochem. Biophys. Res. Commun. 199:1313; 1994.
13. FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA 89:5192-5196; 1992.
14. 14. Seckl, M.; Rozengurt, E. Tyrphostin inhibits bombesin stimulation of tyrosine phosphorylation, c-fos expression and DNA synthesis in Swiss 3T3 cells. J. Biol. Chem. 268:9548-9554; 1993.
15. B receptors are present on small-cell lung cancer cell lines. Cancer Res. 53:5208-5213; 1993.
16. 2+ mobilisation and clonal growth in small-cell lung cancer cells. Cancer Res. 52:6031-6035; 1992.
17. 17. Sethi, T.; Rozengurt E. Multiple neuropeptides stimulate clonal growth of small-cell lung cancer: Effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res. 51:3621-3623; 1991.
18. 2- mobilisation, inositol phosphate accumulation and clonal growth in small-cell lung cancer cells. Cancer Res. 51:1674-1679; 1991.
19. 19. Sethi, T.; Langdon, S.; Smyth, J.; Rozengurt, E. Growth of small-cell lung cancer cells: Stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res. 52:2735s-2742s; 1992.
20. 20. Smyth, J. F.; Fowlie, S. M.; Gregor, A. G.; et al. The impact of chemotherapy on small-cell carcinoma of the bronchus. Q. J. Med. 61:969-976; 1986.
21. 2 bradykinin receptors. FASEB J. 3:2019-2025; 1989.
22. 22. Trepel, J. B.; Moyer, J. D.; Heikkla, R.; Sausville, E. A. Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small-cell lung cancer cell line. Biochem. J. 255:403-410; 1988.
23. 23. Ullrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212; 1990.
24. 24. Wada, E.; Way, J.; Shapiro, H.; et al. cDNA cloning, characterisation and brain region-specific expression of a neuromedin B-preferring bombesin receptor. Neuron 6:421-430; 1991.
25. 25. Woll, P. J.; Rozengurt, E. Multiple neuropeptides mobilise calcium in small cell lung cancer: Effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem. Biophys. Res. Commun. 164:66-73; 1989.
26. 11] substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro. Proc. Natl. Acad. Sci. USA 85:1859-1863; 1988.
27. 27. Zachary, I.; Gil, J.; Lehmann, W.; Sinnett-Smith, J.; Rozengurt, E. Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 88:4577-4581; 1991.
28. FAK): A point of convergence in the action of neuropeptides, integrins and oncogenes. Cell 71:891-894; 1992.